Literature DB >> 18429177

Overview of the vaccinia virus expression system.

B Moss1, P L Earl.   

Abstract

The vaccinia virus expression system differs from others in that transcription occurs in the cytoplasm of mammalian cells rather than in the nucleus. As a vector, vaccinia virus has a number of useful characteristics, including a capacity that permits cloning large fragments of foreign DNA (20+ kbp) with retention of infectivity, a wide host range, a relatively high level of protein synthesis, and "appropriate" transport, secretion, processing, and posttranslational modifications as dictated by the primary structure of the expressed protein and the cell type used. This overview discusses the life cycle of the vaccinia virus along with effects of vaccinia infection. The vaccinia vector expression system is described along with specific steps for expressing genes using these vectors. Important safety considerations are also presented.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18429177     DOI: 10.1002/0471140864.ps0511s13

Source DB:  PubMed          Journal:  Curr Protoc Protein Sci        ISSN: 1934-3655


  6 in total

1.  Synergistic interaction between oncolytic viruses augments tumor killing.

Authors:  Fabrice Le Boeuf; Jean-Simon Diallo; J Andrea McCart; Steve Thorne; Theresa Falls; Marianne Stanford; Femina Kanji; Rebecca Auer; Christopher W Brown; Brian D Lichty; Kelley Parato; Harold Atkins; David Kirn; John C Bell
Journal:  Mol Ther       Date:  2010-03-16       Impact factor: 11.454

2.  Generation of recombinant vaccinia viruses via green fluorescent protein selection.

Authors:  Sergei Popov; Saied Mirshahidi; Sosthène Essono; Ruijiang Song; Xiaowei Wang; Ruth M Ruprecht
Journal:  DNA Cell Biol       Date:  2009-03       Impact factor: 3.311

3.  Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.

Authors:  Nanhai Chen; Clifford J Bellone; Jill Schriewer; Gelita Owens; Torgny Fredrickson; Scott Parker; R Mark L Buller
Journal:  Virology       Date:  2010-11-10       Impact factor: 3.513

Review 4.  Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.

Authors:  Sandeep S Patil; Ivaylo Gentschev; Ingo Nolte; Gregory Ogilvie; Aladar A Szalay
Journal:  J Transl Med       Date:  2012-01-04       Impact factor: 5.531

Review 5.  Oncolytic virotherapy of canine and feline cancer.

Authors:  Ivaylo Gentschev; Sandeep S Patil; Ivan Petrov; Joseph Cappello; Marion Adelfinger; Aladar A Szalay
Journal:  Viruses       Date:  2014-05-16       Impact factor: 5.048

6.  The ubiquitin-proteasome system is required for African swine fever replication.

Authors:  Lucía Barrado-Gil; Inmaculada Galindo; Diego Martínez-Alonso; Sergio Viedma; Covadonga Alonso
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.